Belmont, CA, United States of America

Erica Anne Kraynack

This inventor holds 31 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 7 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Cytokinetics, Inc., Amgen Inc.. Active years: 2005-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Erica Anne Kraynack. Retrieved from https://idiyas.com/inventor/erica-anne-kraynack

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 31 

% Patents Active = 90.3


 

Average Co-Inventor Count = 6.3

ph-index = 17

Forward Citations = 546(Granted Patents)


Location History:

  • South San Francisco, CA (US) (2008 - 2012)
  • Belmont, CA (US) (2005 - 2021)

Company Filing History:


Years Active: 2005-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Pharmaceuticals
Heart Failure
Ureas
Heterocyclic Sulfonamides
Chemical Entities
Compositions
Modulators
Cardiac Sarcomeres
Disubstituted Ureas
Indanyl Urea
Compounds
Methods
31 patents (USPTO):Explore Patents

Title: Erica Anne Kraynack - Innovator from Belmont, CA

Introduction: Erica Anne Kraynack is a pioneering inventor based in Belmont, CA, known for her groundbreaking contributions to various fields.

Latest Patents: Erica Anne Kraynack holds several patents in the areas of technology and healthcare, showcasing her innovative mindset and problem-solving abilities.

Career Highlights: Throughout her career, Erica Anne Kraynack has demonstrated a strong passion for creating solutions that improve people's lives. Her work has been recognized for its creativity and practicality.

Collaborations: Erica Anne Kraynack has collaborated with leading experts in the industry, fostering a culture of innovation and knowledge-sharing to drive progress in her projects.

Conclusion: Erica Anne Kraynack's dedication to innovation and her commitment to making a positive impact through her inventions make her a respected figure in the inventor community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…